Overview

Treatment of Diabetic Neuropathy With Liraglutide

Status:
Completed

Trial end date:
2017-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this trial is to explore whether liraglutide has a long term effect on clinical symptoms and biomarkers in patients with diabetic neuropathy.

Phase:

N/A

Details

Lead Sponsor:

Aalborg Universitetshospital
Aalborg University Hospital

Collaborator:

Novo Nordisk A/S

Treatments:

Liraglutide